HRP20100023T1 - Postupak za pripremu karvedilola i njegovih enantiomera - Google Patents

Postupak za pripremu karvedilola i njegovih enantiomera Download PDF

Info

Publication number
HRP20100023T1
HRP20100023T1 HR20100023T HRP20100023T HRP20100023T1 HR P20100023 T1 HRP20100023 T1 HR P20100023T1 HR 20100023 T HR20100023 T HR 20100023T HR P20100023 T HRP20100023 T HR P20100023T HR P20100023 T1 HRP20100023 T1 HR P20100023T1
Authority
HR
Croatia
Prior art keywords
enantiomers
preparation
carvedilol
molar excess
reaction solvent
Prior art date
Application number
HR20100023T
Other languages
English (en)
Croatian (hr)
Inventor
Trepat Guixer Elisenda
Munoz Alvarez Anna
Pomares Marco Marta
Marquillas Olondriz Francisco
Original Assignee
Zach System S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zach System S.P.A. filed Critical Zach System S.P.A.
Publication of HRP20100023T1 publication Critical patent/HRP20100023T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20100023T 2004-12-09 2010-01-13 Postupak za pripremu karvedilola i njegovih enantiomera HRP20100023T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106438 2004-12-09
PCT/EP2005/056469 WO2006061364A1 (en) 2004-12-09 2005-12-05 Process for the preparation of carvedilol and its enantiomers

Publications (1)

Publication Number Publication Date
HRP20100023T1 true HRP20100023T1 (hr) 2010-02-28

Family

ID=35985349

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100023T HRP20100023T1 (hr) 2004-12-09 2010-01-13 Postupak za pripremu karvedilola i njegovih enantiomera

Country Status (16)

Country Link
US (2) US20090005429A1 (de)
EP (1) EP1838670B1 (de)
JP (1) JP2008523025A (de)
CN (1) CN100591668C (de)
AT (1) ATE445601T1 (de)
CA (1) CA2589699A1 (de)
CY (1) CY1110688T1 (de)
DE (1) DE602005017194D1 (de)
DK (1) DK1838670T3 (de)
ES (1) ES2333537T3 (de)
HR (1) HRP20100023T1 (de)
IL (1) IL183449A0 (de)
PL (1) PL1838670T3 (de)
PT (1) PT1838670E (de)
SI (1) SI1838670T1 (de)
WO (1) WO2006061364A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245974C (zh) 2000-06-28 2006-03-22 特瓦制药工业有限公司 卡维地洛
CN1298322C (zh) 2002-01-15 2007-02-07 特瓦制药工业有限公司 卡维地洛的结晶固体及其制备方法
KR100746455B1 (ko) 2006-02-23 2007-08-03 안국약품 주식회사 고광학순도의 키랄 카베딜롤의 제조방법
WO2008002683A2 (en) 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Polymorphous forms of carvedilol phosphate
CN102190613B (zh) * 2010-03-14 2014-06-25 浙江华海药业股份有限公司 一种卡维地洛的制备方法
AP3221A (en) 2010-03-23 2015-04-30 Siga Technologies Inc Polymorphic forms ST-246 and methods of preparation
WO2015031914A1 (en) * 2013-08-30 2015-03-05 Uti Limited Partnership Store overload-induced calcium release inhibitors and methods for producing and using the same
CN104592096A (zh) * 2014-12-24 2015-05-06 江苏苏南药业实业有限公司 一种s-卡维地洛的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten
EP0893440A1 (de) * 1997-07-22 1999-01-27 Roche Diagnostics GmbH Eine thermodynamisch stabile Modifikation von 1-(4-Carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, Verfahren zu ihrer Herstellung und ihre enthaltende Arznemittel
CN1245974C (zh) * 2000-06-28 2006-03-22 特瓦制药工业有限公司 卡维地洛

Also Published As

Publication number Publication date
PT1838670E (pt) 2009-12-18
PL1838670T3 (pl) 2010-03-31
US20090005429A1 (en) 2009-01-01
EP1838670B1 (de) 2009-10-14
CN100591668C (zh) 2010-02-24
DE602005017194D1 (de) 2009-11-26
ES2333537T3 (es) 2010-02-23
EP1838670A1 (de) 2007-10-03
US20120041044A1 (en) 2012-02-16
CN101072753A (zh) 2007-11-14
WO2006061364A1 (en) 2006-06-15
ATE445601T1 (de) 2009-10-15
JP2008523025A (ja) 2008-07-03
CA2589699A1 (en) 2006-06-15
DK1838670T3 (da) 2010-03-01
IL183449A0 (en) 2007-09-20
CY1110688T1 (el) 2015-06-10
SI1838670T1 (sl) 2010-04-30

Similar Documents

Publication Publication Date Title
HRP20100023T1 (hr) Postupak za pripremu karvedilola i njegovih enantiomera
PE20050077A1 (es) Derivados de 4-pirrolidino-fenil-bencil-eter
DK1678119T3 (da) Fremgangsmåde til fremstilling af 2-dihalogenacyl-3-amino-acrylsyreestere og 3-dihalogenmethyl-pyrazol-4-carboxylsyreestere
RS50918B (sr) Novi estri fluorenkarbonske kiseline, postupak za njihovo pripremanje, kao i njihova upotreba kao lekova
PE20060298A1 (es) Derivados de acido carboxilico de bencimidazolona
CY1112283T1 (el) Μεθοδος για την παρασκευη 17-βινυλ-τριφλικων ως ενδιaμεσα
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
DK1511732T5 (da) Fremgangsmåde til fremstilling af quinolinderivater
AR041816A1 (es) Compuesto de acil-pirrolidina, su uso para preparar una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para prepararlo
CY1111469T1 (el) ΧΡΗΣΗ ΠΑΡΑΓΩΓΩΝ 3-ΦΑΙΝΥΛΘΕΙΟ-1Η-ΙΝΔΟΛΗ-1-ΟΞΙΚΟΥ ΟΞΕΟΣ ΩΣ ΡΥΘΜΙΣΤΕΣ ΤΗΣ ΔΡΑΣΗΣ ΤΟΥ ΥΠΟΔΟΧΕΑ CRTh2
NO20052575L (no) Nye forbindelser, deres fremstilling og anvendelse
PE20020707A1 (es) Compuestos tripeptidicos como inhibidores de la proteasa ns3 del virus de hepatitis c
CL2009000089A1 (es) Procesos de preparacion de un derivado del acido y-amino-o-bifenil-x-metil-pentanoico;compuestos intermediarios y su proceso de preparacion; uso de los compuestos en la sintesis de compuestos inhibidores de nep, utiles en enfermedades cardiovasculares, tales como hipertension, insuficiencia cardiaca congestiva, entre otras.
DE60218703D1 (de) (-)-1-(3,4-dichlorphenyl)-3-azabicyclo ä3.1.0ühexan, zusammensetzungen davon und verwendung als dopamin-wiederaufnahme-hemmer
WO2020016749A3 (en) Chemical process for preparing phenylpiperidinyl indole derivatives
NO20075625L (no) Fremgangsmate for dynamisk opplosning av (substituert) (R)- eller (S) -mandelsyre
AR049023A1 (es) Imidazoles como inihibidores de la hmg-coa reductasa
DK1606276T3 (da) Fremstilling og anvendelse af 2-substituerede 5-oxo-3-pyrazolidincarboxylater
ATE364659T1 (de) Verwendung von isononylbenzoaten als filmbildehilfsmittel
ATE476417T1 (de) Verfahren zur herstellung von carvedilol
DE60327350D1 (de) Verfahren zur herstellung von carvedilol
ATE550326T1 (de) Als modulatoren von hdl einsetzbare verbindungen
IS8306A (is) Augnsamsetningar til að meðhöndla aungháþrýsting
ATE446284T1 (de) Indolderivate mit einer acetylengruppe als ppar- aktivatoren